Related Experiment Video
Updated: Jul 27, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
The anti-proliferative gene TIS21 is involved in osteoclast differentiation
Soo Woong Lee1, Han Bok Kwak, Hong Chan Lee
1National Research Laboratory for Bone Metabolism, Research Center for Proteineous Materials, Chosun University, Gwangju.
Abstract:
The remodeling process of bone is accompanied by complex changes in the expression levels of various genes. Several approaches have been employed to detect differentially-expressed genes in regard to osteoclast differentiation. In order to identify the genes that are involved in osteoclast differentiation, we used a cDNAarray-nylon membrane. Among 1,200 genes that showed a measurable signal, 19 genes were chosen for further study. Eleven genes were up-regulated; eight genes were downregulated. TIS21 was one of the up-regulated genes which were highly expressed in mature osteoclasts. To verify the cDNA microarray results, we carried out RT-PCR and real-time RT-PCR for the TIS21 gene. The TIS21 mRNA level was higher in differentiated-osteoclasts when compared to undifferentiated bone-marrow macrophages. Furthermore, the treatment with 1 mM of a TIS21 antisense oligonucleotide reduced the formation of osteoclasts from the bone-marrow-precursor cells by approximately 30%. These results provide evidence for the potential role of TIS21 in the differentiation of osteoclasts
Insights
This study identifies TIS21 as a gene highly expressed in mature osteoclasts. Inhibiting TIS21 with an antisense oligonucleotide significantly reduced osteoclast formation, suggesting its crucial role in bone remodeling.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Bone remodeling involves complex gene expression changes.
- Identifying genes in osteoclast differentiation is crucial for understanding bone diseases.
Purpose of the Study:
- To identify genes involved in osteoclast differentiation using cDNA microarray.
- To investigate the specific role of TIS21 in osteoclastogenesis.
Main Methods:
- cDNA microarray analysis of 1,200 genes.
- RT-PCR and real-time RT-PCR for TIS21 validation.
- Inhibition of TIS21 using antisense oligonucleotides.
Main Results:
- 19 differentially expressed genes were identified, with 11 up-regulated and 8 down-regulated.
- TIS21 showed high expression in mature osteoclasts and increased mRNA levels post-differentiation.
- TIS21 inhibition reduced osteoclast formation by approximately 30%.
Conclusions:
- TIS21 is significantly upregulated during osteoclast differentiation.
- TIS21 plays a functional role in osteoclast formation.
- TIS21 is a potential therapeutic target for bone remodeling disorders.
Related Concept Videos
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

